Project Grant HT94252510042
Award Date
1/1/25
Completion Date
12/31/28
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
This $847,875 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Virginia aimed at understanding the role of the Schwann cell tumor microenvironment in the development of neurofibromas. The project will take place over 3 years from September 2025 to August 2028. The research seeks to advance scientific understanding of this medical condition relevant to...
This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
This $5,540,949 federal Project Grant award was made by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports focused ultrasound interventions for noninvasive precision therapy in primary and metastatic breast cancers. The award was made to the Rector & Visitors of the University of Virginia (UVA), who will serve as the prime recipient and perform the research over a 4-year period from September 2025 to September 2029. The...
The federal Project Grant award, totaling $6,663,794.00 and effective September 30, 2024, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the "PRECISIE RTD TRIAL: PRECISION WITH RETURN-TO-DUTY DECISIONS IN THE MILITARY" research initiative, which aims to transform healthcare for military service members. The primary awardee, The Geneva Foundation, will conduct advanced biomedical research and...
This federal Project Grant award, valued at $153,309.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the University of Massachusetts to model the spread of airborne pathogens through lung-on-a-chip technology. The research aims to transform healthcare for military service members and the broader public by developing innovative approaches to disease prevention, diagnosis, and treatment. The...
This $777,500 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program will support multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting at the University of Wisconsin - Madison. The 3-year project, running from June 1, 2025 to May 31, 2028, will leverage the university's expertise in medical research and analysis to advance innovative approaches to disease prevention,...
This $999,392 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research initiatives at the University of Houston System. The funding will be used to conduct research on PRMT5 in lupus nephritis, with a performance period from September 1, 2025 through August 31, 2029. The Military Medical Research and Development program focuses on transforming healthcare for military service...
The federal Project Grant award, valued at $234,000.00 and granted by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research on in vivo hyperpolarized MRI of abnormal metabolism in prostate cancer. The award was made to the University of Texas at Dallas, a prominent research university, on September 1, 2025, with a performance period ending on August 31, 2027. The funded research aims to investigate innovative approaches to the...
This federal Project Grant award, valued at $155,500.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is for the University of Wisconsin System to develop a model to study tumor-normal cell interaction in vitro for high-throughput drug screening. The research aims to transform healthcare for military service members and the broader public through innovative biomedical investigations. The one-year project will run from...
This $646,252 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research to uncover cell intrinsic and extrinsic factors governing melanoma dormancy at single-cell resolution. The primary awardee, Trustees of Boston University, will conduct this advanced biomedical research. The University of Virginia will provide academic and technical resources, including experiments generating and validating...